KAVMYL


film-coated tablets
scheduling status
S4
registration number
53/20.2.8/0092.091
What KAVMYL contains
Abacavir Dolutegravir Lamivudine.
other ingredients
Microcrystalline cellulose, mannitol, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, sodium starch glycolate, Opadry II brown (polyvinyl alcohol, titanium dioxide, macrogol, talc, iron oxide red, black iron oxide.
Therapeutic classification
J05AR13.
© 2026 SAHPRA. ALL RIGHTS RESERVED